Current controversies for aneurysms Unruptured aneurysms UPDATE ON - - PowerPoint PPT Presentation

current controversies for aneurysms
SMART_READER_LITE
LIVE PREVIEW

Current controversies for aneurysms Unruptured aneurysms UPDATE ON - - PowerPoint PPT Presentation

2/16/2019 Current controversies for aneurysms Unruptured aneurysms UPDATE ON INTRACRANIAL What to do with small aneurysms? Predicting aneurysms at high risk for rupture ? ANEURYSMS AND SAH What treatment is best? Nerissa U. Ko,


slide-1
SLIDE 1

2/16/2019 1

UPDATE ON INTRACRANIAL ANEURYSMS AND SAH

Nerissa U. Ko, MD, MAS Recent Advances in Neurology February 15, 2019

Current controversies for aneurysms

  • Unruptured aneurysms
  • What to do with small aneurysms?
  • Predicting aneurysms at high risk for rupture?
  • What treatment is best?
  • Ruptured aneurysms
  • Treatment trends since ISAT
  • Is coiling still the best treatment?
  • Are outcomes better?

Guideline recommendations

  • Family history > 2 first

degree family members with IA or SAH

  • Genetic risk factors
  • Polycystic kidney disease
  • Ehler’s-Danlos, aortic

coarctation, microcephalic

  • steodysplastic primordial

dwarfism

  • History of prior SAH
  • Non-invasive imaging

initially 6-12 months (CTA/MRA/DSA)

  • Follow-up one year or

every other year to determine if:

  • Aneurysm size > 7mm
  • Aneurysm enlargement
  • Consideration for treatment
slide-2
SLIDE 2

2/16/2019 2

Stroke 2018; 49(9): 2268–2275. Current Opinion in Neurology 2019; 32(1): 49–53.

Balancing Risks and Benefits

  • Risk of rupture
  • Risk paradox of the

small aneurysm

  • Risk of complications

with preventative treatment

  • Coiling preferred in older

patients

  • Coil vs clip for others?
  • Medical therapy?
  • Quality of life with

aneurysm diagnosis

  • Follow-up imaging
  • No imaging in <3mm
  • Growth predicts rupture

risk, other morphology

  • Still overall small risk

increase

  • ELAPSS score for

growth risk

Neurology Apr 2017, 88 (17) 1600-1606;

ELAPSS score Unruptured Aneurysm Treatment

slide-3
SLIDE 3

2/16/2019 3

JAMA Neurol. Published online December 28, 2018 Current Opinion in Neurology 2019; 32(1): 36–42.

Updates from ISC 2019

  • Trend for rising costs of treatment for UIAs
  • Regional variability in aSAH treatment and outcomes
  • Predicting high risk aneurysms:
  • UIA growth associated with size, multiplicity, HTN
  • PHASES, UIATS predictive scores not accurate in age > 58
  • Novel Imaging to predict rupture/growth
  • Flow dynamics
  • Vessel wall imaging with pathology
  • Automated CT scan readers
  • Biomarkers as predictors
  • Inflammatory markers in blood and CSF

Updates from ISC 2019

  • Innovations in endovascular treatment
  • New hydrogel coils had less recanalization compared to bare

platinum coils (HEAT trial)

  • Newer flow diverter with improved outcomes in giant/wide-necked

aneurysm (SCENT trial)

  • Preventative treatment for UIAs
  • Although more UIAs were treated overall aneurysm mortality is

unchanged

  • Japanese study preferred coil to clip for UIAs in elderly
  • Less readmissions post procedure with coil vs clip for UIAs
  • Pragmatic trial of clipping vs coiling of UIAs is ongoing
  • Medical therapy trial PROTECT-U enrolling (asa and SBP <120)
slide-4
SLIDE 4

2/16/2019 4

Summary

  • Small aneurysms have a very low risk of

growth and rupture

  • Paradox of infrequent/no monitoring in small

aneurysms, but small aneurysms do rupture

  • Selecting those at risk remains problematic
  • Role for imaging, biomarkers
  • Treatment risks for both coiling and clipping
  • Medical and interventional treatment trials
  • ngoing